NKGen Biotech Stock (NASDAQ: NKGN) stock price, news, charts, stock research, profile.
Open | $1.27 |
Close | - |
Volume / Avg. | 118.06K / 1.52M |
Day Range | 1.21 - 1.33 |
52 Wk Range | 0.78 - 6.70 |
Market Cap | $32.60M |
P/E Ratio | - |
Dividend Yield | - |
Quote.Metrics.exchange | NASDAQ |
RSI | 48 |
Short Interest | 6.46% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NKGen Biotech (NASDAQ:NKGN) through any online brokerage.
Other companies in NKGen Biotech’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), Gain Therapeutics (NASDAQ:GANX) and Aligos Therapeutics (NASDAQ:ALGS).
There is no analysis for NKGen Biotech.
There is no analysis for NKGen Biotech to provide a consensus price target.
The stock price for NKGen Biotech (NASDAQ: NKGN) is $1.31 last updated Today at June 26, 2024 at 2:35 PM EDT.
There are no upcoming dividends for NKGen Biotech.
NKGen Biotech’s Q2 earnings are confirmed for Friday, August 16, 2024.
There is no upcoming split for NKGen Biotech.
NKGen Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.